Vancomycin Therapeutic Drug Monitoring (TDM) and Its Association with Clinical Outcomes: A Retrospective Cohort
Background: Therapeutic drug monitoring (TDM) has proven effectiveness in maintaining efficacy and reducing toxicities associated with vancomycin. A trough level of (15-20 mg/L) for MRSA serious infections is recommended. Therapeutic failure is of concern due to suboptimal routine vancomycin utiliza...
Saved in:
Main Authors: | Juhaina Salim Al-Maqbali (Author), Zahra Al Shukri (Author), Nawf Al Sabahi (Author), Intisar AL-Riyami (Author), Abdullah M. Al Alawi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical outcomes in patients hospitalised with dysmagnesemia in the Northern Territory of Australia: a retrospective, longitudinal data-linkage study
by: Juhaina Al-Maqbali, et al.
Published: (2024) -
Incidence, patterns, risk factors and clinical outcomes of intravenous acyclovir induced nephrotoxicity
by: Abdullah M. Al-Alawi, et al.
Published: (2022) -
The Prevalence and Impact of Evidence-Based Medications on Cardiovascular and Cerebrovascular Outcomes in Patients with Acute Coronary Syndrome Post-Revascularization in Oman
by: Dalia Ahmed Al-Hadithy, et al.
Published: (2023) -
The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin-A Pilot Study
by: Paul Firman, et al.
Published: (2022) -
Therapeutic drug monitoring of vancomycin in an obese patient with renal insufficiency
by: Said Abuhasna, et al.
Published: (2011)